$19.51 -0.55 (%) Aegerion Pharmaceuticals Inc - NASDAQ

Jul. 29, 2015 | 04:00 PM

Partner Headlines

  1. Benzinga's Top Upgrades

    Benzinga | Jul. 28, 2015 | 09:09AM EST
  2. Jefferies Upgrades Aegerion Pharma To Buy, Sees Positively Skewed Risk/Reward

    Benzinga | Jul. 28, 2015 | 08:33AM EST
  3. Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program, 71K Shares At $18.83

    Benzinga | Jul. 13, 2015 | 16:11PM EST
  4. Benzinga's Top Downgrades

    Benzinga | Jul. 6, 2015 | 09:45AM EST
  5. Guggenheim Securities Downgrades Aegerion Pharmaceuticals To Sell

    Benzinga | Jul. 6, 2015 | 09:43AM EST
  6. Aegerion Pharmaceuticals Appoints Gregory Perry as CFO

    Benzinga | Jun. 25, 2015 | 07:30AM EST
  7. Aegerion Pharmaceuticals Announces Key Additions to Medical Affairs and Drug Safety

    Benzinga | Jun. 16, 2015 | 16:10PM EST
  8. Activist Discloses 5.7% Stake In Aegerion Pharmaceuticals

    Benzinga | Feb. 5, 2015 | 13:44PM EST
  9. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  10. Report: Holders Push For Sale At Aegerion Pharmaceuticals

    Benzinga | Jan. 14, 2015 | 15:06PM EST
  11. Big Short Interest On These 5 Biotech Stocks

    Benzinga | Jan. 12, 2015 | 15:36PM EST
  12. Morning Market Gainers

    Benzinga | Jan. 12, 2015 | 09:42AM EST
  13. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  14. Gilead Sciences Releases Impressive Results for Hepatitis C Drug

    GuruFocus | Nov. 12, 2014 | 11:56AM EST
  15. The Future Of Aegerion Pharmaceutical's Stock

    Benzinga | Nov. 3, 2014 | 18:13PM EST
  16. Meet The Biopharma Stock That Lost 34% Last Week

    Benzinga | Nov. 3, 2014 | 18:13PM EST
  17. Midday Losers From October 31: Aegerion Pharmaceuticals, Bottomline Technologies, Digital Globe

    Benzinga | Oct. 31, 2014 | 13:38PM EST
  18. Mid-Day Market Update: GoPro Jumps On Upbeat Results; Tempur Sealy Shares Dip

    Benzinga | Oct. 31, 2014 | 13:34PM EST
  19. Mid-Morning Market Update: Markets Open Higher; Clorox Earnings Top Street View

    Benzinga | Oct. 31, 2014 | 11:06AM EST
  20. Morning Market Losers

    Benzinga | Oct. 31, 2014 | 10:08AM EST
  21. Benzinga's Top Downgrades

    Benzinga | Oct. 31, 2014 | 08:55AM EST
  22. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 31, 2014 | 08:21AM EST
  23. Jefferies Downgrades Aegerion Pharmaceuticals To Hold

    Benzinga | Oct. 31, 2014 | 07:54AM EST
  24. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  25. Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program

    Benzinga | Oct. 8, 2014 | 16:06PM EST
  26. Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program

    Benzinga | Sep. 9, 2014 | 08:07AM EST
  27. Aegerion Pharmaceuticals Announces Resolution Of Warning Letter for JUXTAPID (lomitapide) Capsules

    Benzinga | Aug. 27, 2014 | 07:06AM EST
  28. Markets Open Higher; Priceline Issues Downbeat Profit Forecast

    Benzinga | Aug. 11, 2014 | 11:32AM EST
  29. US Stock Futures Signal Higher Start On Wall Street

    Benzinga | Aug. 11, 2014 | 07:44AM EST
  30. Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR

    GuruFocus | Aug. 4, 2014 | 11:11AM EST
  31. The FED Continues To Taper; Indices Rebound Slightly

    Benzinga | Jul. 30, 2014 | 15:07PM EST
  32. Twitter Jumps On Upbeat Results; DreamWorks Shares Slide

    Benzinga | Jul. 30, 2014 | 12:47PM EST
  33. Markets Mixed; Sprint Posts Profit

    Benzinga | Jul. 30, 2014 | 11:29AM EST
  34. Benzinga's Volume Movers

    Benzinga | Jul. 30, 2014 | 10:50AM EST
  35. Morning Market Movers

    Benzinga | Jul. 30, 2014 | 09:46AM EST
  36. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 30, 2014 | 08:06AM EST
  37. Stocks Hitting 52-Week Lows

    Benzinga | Jul. 18, 2014 | 13:19PM EST
  38. 5-Star Biotech Stock Watch: Aegerion Pharmaceuticals

    Benzinga | Jul. 9, 2014 | 15:30PM EST
  39. Stocks Hitting 52-Week Lows

    Benzinga | Jul. 9, 2014 | 10:16AM EST
  40. Weekly CEO Buys Highlight: GEO, TRUE, BANC, AEGR, CLMS

    GuruFocus | Jun. 2, 2014 | 11:45AM EST
  41. Four CEOs Reporting Large Insider Buys

    GuruFocus | May. 9, 2014 | 19:29PM EST
  42. Morning Market Losers

    Benzinga | May. 7, 2014 | 09:48AM EST
  43. UPDATE: Aegerion Pharma Commences Phase 3 Clinical Trial in Japan, Will Evaluate Lomitapipde for Treatment of HoFH

    Benzinga | Apr. 9, 2014 | 08:07AM EST
  44. Aegerion's JUXTAPID Capsules Approved in Mexico for Treatment of Homozygous Familial Hypercholesterolemia

    Benzinga | Jan. 20, 2014 | 08:10AM EST
  45. Leerink Swann Reiterates on Aegerion Pharmaceuticals as Weakness is Overdone

    Benzinga | Nov. 19, 2013 | 11:26AM EST
  46. Canaccord Genuity Reiterates on Aegerion Pharmaceuticals as Selling is Overdone

    Benzinga | Nov. 19, 2013 | 10:50AM EST
  47. Aegerion Pharmaceuticals Presents Data From Phase 3 Extension Study of JUXTAPID(TM) (lomitapide) Capsules in Homozygous Familial Hypercholesterolemia (HoFH) at AHA Scientific Sessions

    Benzinga | Nov. 18, 2013 | 16:04PM EST
  48. UPDATE: Deutsche Bank Reiterates on Aegerion Pharmaceuticals Following Company Analyst Day

    Benzinga | Nov. 13, 2013 | 10:23AM EST
  49. Market Wrap For November 8: Markets Erase Thursday's Losses; Dow Companies Dominate Headlines

    Benzinga | Nov. 8, 2013 | 16:57PM EST
  50. Benzinga's Top Pre-Market Gainers

    Benzinga | Jul. 30, 2013 | 08:12AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!